2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product

Product Details
Application: Cosmetic Surgery Center
Gender: Unisex
Side Effect: No
Diamond Member Since 2020

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
13
Year of Establishment
2016-05-25
  • 2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product
  • 2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product
  • 2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product
  • 2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product
  • 2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product
  • 2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product
Find Similar Products

Basic Info.

Model NO.
saxenda
Efficacy
Loss Weight
Model No.
Ozempics
Shelf Life
2years
Treatment Cycle
Single Treatment Can Be Performed Again After 3 Mo
Function
Fat Dissolve
Feature
Weight Loss
Transport Package
Carton with Foam
Specification
6mg/ml
Trademark
saxendas

Product Description

 

Product Description


Saxends is an FDA-approved prescription injectable medicine that may help some adults with excess weight (body mass index [BMI]≥27) who also have weight-related medical problems or obesity (BMI ≥30), lose weight and keep it off. Saxend should be used with a reduced-calorie meal plan and increased physical activity.

What is Saxenda®

Saxend® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxend® should be used with a reduced calorie diet and increased physical activity. 

  • Saxenda® and Victoza® have the same active ingredient, liraglutide, and should not be used together or with other GLP-1 receptor agonist medicines
  • It is not known if Saxenda® is safe and effective when taken with other prescription, over-the-counter medicines, or herbal weight-loss products
  • It is not known if Saxenda® is safe and effective in children under 12 years of age
  • It is not known if Saxenda® is safe and effective in children aged 12 to 17 years with type 2 diabete


2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product




 

2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product2023 Stock Korea FDA Approve Saxenda Liraglutide Injection 3 Mg Lipolysis Product

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier
People who viewed this also viewed